The content is available as a PDF (333.1 KB).
editorial . 2020 Apr 29:qcaa033. doi: 10.1093/ehjqcco/qcaa033
A Marker of Systemic Inflammation or Direct Cardiac Injury: Should Cardiac Troponin Levels be Monitored in COVID-19 Patients?
Bassam Atallah
q1,q2, Saad I Mallah
q3, Laila AbdelWareth
q4, Wael AlMahmeed
q5, Gregg C Fonarow
q6,✉
Bassam Atallah
q1Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates
q2
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States of America
Find articles by Bassam Atallah
Saad I Mallah
q3School of Medicine, Royal College of Surgeons in Ireland – Bahrain, Kingdom of Bahrain
Find articles by Saad I Mallah
Laila AbdelWareth
q4Department of Clinical Pathology, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates
Find articles by Laila AbdelWareth
Wael AlMahmeed
q5
Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates
Find articles by Wael AlMahmeed
Gregg C Fonarow
q6
Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California, United States of America
Find articles by Gregg C Fonarow
q1Department of Pharmacy Services, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates
q2
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, Cleveland, OH, United States of America
q3School of Medicine, Royal College of Surgeons in Ireland – Bahrain, Kingdom of Bahrain
q4Department of Clinical Pathology, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates
q5
Heart and Vascular Institute, Cleveland Clinic Abu Dhabi, Al Maryah Island, Abu Dhabi, United Arab Emirates
q6
Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, California, United States of America
✉
Correspondence: Dr Gregg C. Fonarow, MD, FACC. Ahmanson–UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 Le Conte Avenue, Room 47-123 CHS, Los Angeles, 90095-1679, CA, USA. gfonarow@mednet.ucla.edu
Received 2020 Apr 14; Revised 2020 Apr 18; Accepted 2020 Apr 22.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2020. For permissions please email: journals.permissions@oup.com.
This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model)
This article is made available via the PMC Open Access Subset for unrestricted re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the COVID-19 pandemic or until permissions are revoked in writing. Upon expiration of these permissions, PMC is granted a perpetual license to make this article available via PMC and Europe PMC, consistent with existing copyright protections.
PMCID: PMC7197587 PMID: 32348472